- Palis H, Hu K, Tu A, Scheuermeyer F, Staples JA, Moe J, Haywood B, Desai R, Xavier CG, Xavier JC, Crabtree A, Slaunwhite A. Chronic disease diagnoses and health service use among people who died of illicit drug toxicity in British Columbia, Canada. BMC Med. 2024 Nov 27;22(1):479. doi: 10.1186/s12916-024-03646-y. PMID: 39593053; PMCID: PMC11600560. Click here
- Dabla, K., Newby, M., Kang, M.G., Moe, J. How to navigate health promotion in the digital age—Social media and harm reduction among young adults. BCMJ, Vol. 66, No. 8, October, 2024, Page(s) 286-290. Click here
- Khan M, Nicole X, Crabtree A, Moe J, Nasmith T, Daly-Grafstein D, Brubacher JR, Slaunwhite AK, Staples JA. “Before medically advised” departure from hospital and subsequent drug overdose: a population-based cohort study. CMAJ. 2024 Sep 22;196(31):E1066-E1075. doi: 10.1503/cmaj.240364. PMID: 39313269; PMCID: PMC11426346. Click here
- Kong A, Long V, Wang E, Lau A, Moe J. (May 06, 2025) Exploratory Analysis on the Role of Video Tools and Multidisciplinary Healthcare Providers to Aid Counselling for Buprenorphine/Naloxone Induction Within the Evaluating Microdosing in the Emergency Department Study. Cureus 17(5): e83593. doi:10.7759/cureus.83593. Click here
- Hussey, A., Pozsgay, K., Crawford, C.M.L., Wang, Y.E., Lau, A., Kestler, A., Moe J. Using quality improvement approaches to increase emergency department provider engagement in research participant enrollment during COVID-19 and opioid overdose public health emergencies. Can J Emerg Med 26, 349–358 (2024). https://doi.org/10.1007/s43678-024-00691-7. Click here
- Moe, J., Buxton, J.A., Wang, Y.E. et al. Physiologic oxygen responses to smoking opioids: an observational study using continuous pulse oximetry at overdose prevention services in British Columbia, Canada. Harm Reduct J 21, 89 (2024). https://doi.org/10.1186/s12954-024-01011-z. Click here
- Moe J, Koh J, Ma JA, Pei LX, MacLean E, Keech J, Maguire K, Ronsley C, Doyle-Waters MM, Brubacher JR. Screening for harmful substance use in emergency departments: a systematic review. Int J Emerg Med. 2024 Apr 8;17(1):52. doi: 10.1186/s12245-024-00616-2. PMID: 38584266; PMCID: PMC11000386. Click here
- Moe J, Chavez T, Marr C, Cameron F, Feldman-Kiss D, Wang YE, Xavier JC, Mamdani Z, Purssell RA, Salmon A, Buxton JA. Feeling safer: effectiveness, feasibility, and acceptability of continuous pulse oximetry for people who smoke opioids at overdose prevention services in British Columbia, Canada. Harm Reduct J. 2024 Feb 20;21(1):45. doi: 10.1186/s12954-024-00963-6. PMID: 38378610; PMCID: PMC10877878. Click here
- Badke K, Small SS, Pratt M, Lockington J, Gurney L, Kestler A, Moe J. Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study. BMC Health Serv Res. 2024 Feb 15;24(1):211. doi: 10.1186/s12913-023-10271-7. PMID: 38360620; PMCID: PMC10870432. Click here
- MacKinnon N, Lane D, Scheuermeyer F, Kaczorowski J, Dong K, Orkin AM, Daoust R, Moe J, Andolfatto G, Klaiman M, Yan J, Koh JJ, Crowder K, Atkinson P, Savage D, Stempien J, Besserer F, Wale J, Kestler A. Factors associated with frequent buprenorphine / naloxone initiation in a national survey of Canadian emergency physicians. PLoS One. 2024 Feb 5;19(2):e0297084. doi: 10.1371/journal.pone.0297084. PMID: 38315732; PMCID: PMC10843078. Click here
- Lakkadghatwala R, Lane D, Scheuermeyer F, Hilburt J, Buxton J, Johnson C, Nolan S, Sutherland C, Moe J, Daoust R, Dong K, Christenson J, Miles I, Orkin A, Whyte M, Kestler A. An emergency-department-initiated outreach program for patients with opioid use disorder is associated with an increase in agonist therapy and engagement in addictions care: a one-year cohort study. Subst Abuse Treat Prev Policy. 2024 Feb 21;19(1):14. doi: 10.1186/s13011-023-00578-3. PMID: 38383467; PMCID: PMC10880351. Click here
- Duncan K, Scheuermeyer F, Lane D, Ahamad K, Moe J, Dong K, Nolan S, Buxton J, Miles I, Johnson C, Christenson J, Whyte M, Daoust R, Garrod E, Badke K, Kestler A. Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packs. CJEM. 2023 Oct;25(10):802-807. doi: 10.1007/s43678-023-00568-1. Epub 2023 Aug 22. PMID: 37606738; PMCID: PMC12129063. Click here
- Galarneau LR, Scheuermeyer FX, Hilburt J, O’Neill ZR, Barbic S, Moe J, Buxton JA, Orkin AM, Kaczorowski J, Dong K, Tobin D, Miles I, Bath M, Grier S, Garrod E, Kestler A. Qualitative Exploration of Emergency Department Care Experiences Among People With Opioid Use Disorder. Ann Emerg Med. 2023 Jul;82(1):1-10. doi: 10.1016/j.annemergmed.2023.02.007. Epub 2023 Mar 25. PMID: 36967276; PMCID: PMC12129082. Click here
- Xavier CG, Kuo M, Desai R, Palis H, Regan G, Zhao B, Moe J, Scheuermeyer FX, Gan WQ, Sabeti S, Meilleur L, Buxton JA, Slaunwhite AK. Association between toxic drug events and encephalopathy in British Columbia, Canada: a cross-sectional analysis. Subst Abuse Treat Prev Policy. 2023 Jul 7;18(1):42. doi: 10.1186/s13011-023-00544-z. PMID: 37420239; PMCID: PMC10329314. Click here
- Palis H, Barocas JA, Moe J, Scow M, Sedgemore KO, Slaunwhite AK, Buxton JA. Rising rates of infective endocarditis in North America: An urgent need for attention to the rapidly changing unregulated drug supply. Int J Drug Policy. 2023 Aug;118:104110. doi: 10.1016/j.drugpo.2023.104110. Epub 2023 Jun 28. PMID: 37390695. Click here